Schober M, Faber K. Inverting hydrolases and their use in enantioconvergent biotransformations.
Trends Biotechnol 2013;
31:468-78. [PMID:
23809848 PMCID:
PMC3725421 DOI:
10.1016/j.tibtech.2013.05.005]
[Citation(s) in RCA: 33] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2013] [Revised: 05/14/2013] [Accepted: 05/14/2013] [Indexed: 01/23/2023]
Abstract
Enantioconvergent processes overcome the 50%-yield limits of kinetic resolution.
Inverting enzymes are key catalysts for enantioconvergent processes.
Enzyme engineering provided improved variants of inverting enzymes.
Owing to the more abundant occurrence of racemic compounds compared to prochiral or meso forms, most enantiomerically pure products are obtained via racemate resolution. This review summarizes (chemo)enzymatic enantioconvergent processes based on the use of hydrolytic enzymes, which are able to invert a stereocenter during catalysis that can overcome the 50%-yield limitation of kinetic resolution. Recent developments are presented in the fields of inverting or retaining sulfatases, epoxide hydrolases and dehalogenases, which allow the production of secondary alcohols or vicinal diols at a 100% theoretical yield from a racemate via enantioconvergent processes.
Collapse